Skip to main content

Advertisement

Log in

Brain hyper-excitability in DPPX ataxia

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Boronat B, Jeffrey M, Gelfand M et al (2013) Encephalitis and antibodies to DPPX, a subunit of Kv42 potassium channels. Ann Neurol 73(1):120–128

    Article  CAS  Google Scholar 

  2. Tobin W, Lennon V, Komorowki L et al (2014) DPPX potassium channel antibody. Neurology 83(20):1797–1803

    Article  CAS  Google Scholar 

  3. Hara M, Arino H, Sabater L et al (2017) DPPX antibody-associated encephalitis: main syndrome and antibody effects. Neurology 88(14):1340–1348

    Article  CAS  Google Scholar 

  4. Peipgras J, Holtje M, Klaus M et al (2015) Anti-DPPX encephalitis. Pathogenic effects of antibodies on gut and brain neurons. Neurology 85(10):890–897

    Article  Google Scholar 

  5. Currie S, Hadjivassiliou M, Craven I et al (2013) Magnetic resonance spectroscopy of the brain. Postgrad Med J 89(1048):94–106

    Article  CAS  Google Scholar 

  6. Shibaski H, Hallett M (2005) Electrophysiological studies of myoclonus. Muscle Nerve 31(2):157–174

    Article  Google Scholar 

  7. Cassim F, Houdayer E (2006) Neurophysiology of myoclonus. Clin Neurophysiol 36(5–6):281–291

    Article  CAS  Google Scholar 

  8. Croccu G, Aminoff MJ, Curio G et al (2008) Recommendations for the clinical use of somatosensory-evoked potentials. Clin Neurophysiol 119(8):1705–1719

    Article  Google Scholar 

  9. Hadjivassiliou M, Graus F, Honnorat J et al (2017) Diagnostic criteria for primary autoimmune cerebellar ataxia-guidelines from an international task force on immune-mediated cerebellar ataxias. Cerebellum. https://doi.org/10.1007/s12311-020-01132-8

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Dr Patrick Waters for his work in setting up the DPPX assay. This is a summary of independent research carried out at the NIHR Sheffield Biomedical Research Centre (Translational Neuroscience). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marios Hadjivassiliou.

Ethics declarations

Conflicts of interest

The authors have no conflicts of interest to disclose.

Ethical standards

This article summarizes observational case series of 3 patients with DPPX-ARA being managed at the Sheffield Ataxia Centre (SAC), Sheffield UK. The South Yorkshire Research Ethics Committee has confirmed that no ethical approval is indicated given that immunosuppression is a recognized treatment for DPPX-ARA and that all investigations/interventions were clinically indicated and did not form part of a research study.

Data access, responsibility and analysis

The corresponding author had full access to all the data and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pattrick, M., Sarrigiannis, P.G., Kruger, S. et al. Brain hyper-excitability in DPPX ataxia. J Neurol 267, 3096–3099 (2020). https://doi.org/10.1007/s00415-020-10182-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-020-10182-1

Navigation